Two university spin-offs emerge | Chemical & Engineering News
Volume 94 Issue 27 | p. 15 | Concentrates
Issue Date: July 4, 2016

Two university spin-offs emerge

Department: Business
Keywords: start-ups, biotechnology, university spin-off

Morphic Therapeutic has raised $51.5 million in a first round of venture capital funding from investors including Pfizer and AbbVie. Founded to translate advances from the lab of Harvard Medical School professor Timothy A. Springer, Morphic is developing small molecules that treat disease by targeting cell membrane proteins called integrins. Meanwhile, Storm Therapeutics has raised about $16 million in a first round of funding from investors including Pfizer and Merck & Co. A spin-off from the University of Cambridge’s Gurdon Institute, Storm seeks to develop small-molecule drugs that target RNA-modifying enzymes involved in cancer.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment